Cargando…
Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites
BACKGROUND: Substandard medicines, whether the result of intentional manipulation or lack of compliance with good manufacturing practice (GMP) or good distribution practice (GDP), pose a significant potential threat to patient safety. Spontaneous adverse drug reaction reporting systems can contribut...
Autores principales: | Juhlin, Kristina, Karimi, Ghazaleh, Andér, Maria, Camilli, Sara, Dheda, Mukesh, Har, Tan Siew, Isahak, Rokiah, Lee, Su-Jung, Vaughan, Sarah, Caduff, Pia, Norén, G. Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544545/ https://www.ncbi.nlm.nih.gov/pubmed/25687792 http://dx.doi.org/10.1007/s40264-015-0271-2 |
Ejemplares similares
-
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase(®)
por: Chandler, Rebecca E., et al.
Publicado: (2016) -
Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria
por: Yue, Qun-Ying, et al.
Publicado: (2022) -
Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre
por: Star, Kristina, et al.
Publicado: (2019) -
VigiAccess: Promoting public access to VigiBase
por: Shankar, Pathiyil Ravi
Publicado: (2016) -
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
por: Sandberg, Lovisa, et al.
Publicado: (2020)